Fate Therapeutics had a rough day and is now down -5.65%. Investors weren't too impressed with the future outlook for the Biotechnology company which caused some selling on weak demand.
Fate Therapeutics doesn't seem to be at a very clear reversal point in either direction. Fate Therapeutics has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are up 4.28 percent. FATE might find some support at the 6.87 level, buyers might push the price back up from here. But it's not very clear what will happen.
Fate Therapeutics has an overall positive view by the analysts. The current Analysts Sentiment Score is 130.11. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Bank of America gave a boost to their price target and moved to $6.00 from $2.00 on 2024-03-28. On 2024-03-19 HC Wainwright reiterated their rating of Neutral and added a price target of $7.00. Oppenheimer reiterated a rating of Market Perform on 2024-02-27. Wedbush provided a price target boost of 133.33% to $7.00 from $3.00 on 2024-02-27. BMO Capital Markets provided a price target boost of 16.67% to $7.00 from $6.00 on 2024-02-27. On 2024-02-27 Barclays increased their price target by 66.67% to $10.00. Morgan Stanley gave a boost to their price target and moved to $7.00 from $3.00 on 2024-02-27. Mizuho announced a lowering of their price target to $8.00 from $12.00 on 2023-11-20. Wells Fargo & Company dropped their price target by -16.67% to $5.00 on 2023-11-09. Cantor Fitzgerald announced that they are reiterating a rating of Neutral on 2023-09-07 and they set their price target at $5.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| FATE | 130.11 | 0 | 0 | 279.04 | -18.83 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| FATE | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| FATE | 7.69 | %14.9 | 6.1 | -35.31 | 13800000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 104 | -1.43 | -5.45 | -9.47 | 0.51 | 37.33 | 12.75 | 37.26 | 33.18 | 13.74 | 12.82 | -13905.94 | -11063.75 | 3.37 | 24.04 | 9.58 | 70.99 |
| Healthcare | 247 | -0.55 | -3.57 | -8.13 | -2.68 | 21.75 | 2.46 | 41.55 | 31.33 | 10.68 | 11.04 | -12888.05 | -11534.39 | 4.96 | 17.31 | 6.93 | 50.93 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| FATE |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 1.13 | -1.94 | -6.22 | -23.10 | -12.41 | 36.21 | 2.97 | 12 | 57.64 | 50.13 | 37.40 | -2101.92 | -9760.98 | 0 | 150 | 15.3247 |
| EDIT | Editas Medicine, Inc. Com | 1.06 | -2.62 | -11.11 | -27.65 | -30.53 | -15.95 | -29.35 | 26 | 1.11 | -0.78 | -6.75 | -18653.05 | -1877.60 | 0 | 100 | 16.4101 |
| BEAM | Beam Therapeutics Inc. Co | 1.03 | -1.69 | -7.00 | -28.93 | -4.09 | 30.17 | -20.57 | 37 | 27.56 | 27.45 | 18.28 | -12310.25 | -3714.82 | 0 | 0 | 18.782 |
| VCYT | Veracyte, Inc. | 1.02 | -0.34 | -1.21 | -9.27 | -26.46 | -7.96 | -15.82 | 16 | -6.77 | -4.31 | -2.36 | -13628.83 | -197.98 | 0 | 125 | 4.97884 |
| RCKT | Rocket Pharmaceuticals, I | 0.99 | -0.81 | -3.00 | -14.41 | -18.08 | 36.52 | 25.55 | 38 | 12.18 | 32.42 | 36.89 | -2746.04 | -17665.95 | 0 | 0 | 9.12889 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
